Illustration by Moukkaa
Company Information
As of 10/26/22
Country
U.S.
Headquarters
Somerset, N.J.
Industry
Pharmaceuticals
CEO
Alessandro Maselli
Website
Company Type
Public
Ticker
CTLT
Revenues ($M)
$4,703
Profits ($M)
$513
Market Value ($M)
$13,377
Employees
17,300
Revenue and net income for the four quarters ended on or before April 30, 2022. Market value as of Oct. 17, 2022.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$3,998
29.2%
Profits ($M)
$585
165.1%
Assets ($M)
$9,112
-
Total Stockholder Equity ($M)
$4,274
-
Profit Ratios
Profit as % of Revenues
14.6%
Profits as % of Assets
6.4%
Profits as % of Stockholder Equity
13.7%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
311
EPS % Change (from 2020)
172.8%
EPS % Change (5 year annual rate)
28.4%
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2021)
23%
Total Return to Investors (5 year, annualized)
36.6%
Total Return to Investors (10 year, annualized)
-
Catalent Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2021 | $3,094.322.9% | $220.760.6% | $7,776.5 | $3,505.4 |
| 2020 | $2,5182.2% | $137.464.4% | $6,184 | $2,288.2 |
| 2019 | $2,463.418.7% | $83.6-23.9% | $4,531.1 | $1,086.7 |
| 2018 | $2,075.412.3% | $109.8-1.5% | $3,454.3 | $723.5 |
| 2017 | $1,8480.9% | $111.5-47.5% | $3,091 | $636 |
